Clinical Trials news from FierceHealthcare
NewsTreatment guidelines boast little scientific support
Medical best practices have been masquerading as evidence-based clinical practices. Of the thousands of treatment guidelines from the Infectious Diseases Society of America, which represents Read more...
Feds indict Synthes over off-label promotions
In recent years, orthopedic product maker Synthes Inc. chose a carefully-selected panel of surgeons and paid for them to attend training sessions on its new bone-mending cement. The cement, Norian Read more...
Stryker faces two new investigations
Devicemaker Stryker Corp. has been targeted by two investigations, one looking at its relationship with doctors, and the other related to compliance issues regarding one of its products. For one Read more...
Women, minority groups concerned over 'comparative effectiveness'
Women and minorities are up in arms over how some of the money in the recently signed economic stimulus package will be used. According to the Kaiser Network, and first reported by The New York Read more...
FDA slammed by HHS OIG for lax conflict-of-interest oversight
A new report from the HHS inspector general's office comes down hard on the FDA, arguing that the agency isn't doing enough to make sure clinical-trial sponsors stay on top of their researchers' Read more...
Comparative effectiveness institute may lead to more pragmatic studies
What will it mean if advocates succeed in their lobbying for a Institute for Comparative Effectiveness Research? Aside from straightforward comparative effectiveness research, it's also likely to Read more...
Boy wins right to take experimental drug
While the lawsuit was not intended to change the rules regarding clinical trials generally, observers are wondering whether a recent case may indeed change them for patients who, drugmakers say, Read more...
Suit challenges biotech firm over last-chance drug
In another case challenging the limits of "compassionate use" for drugs not approved by the FDA, the mother of a gravely-ill teenager has filed a lawsuit demanding access to an experimental drug. The Read more...
Merck drug, suicide linked?
Is there a possible link between the Merck allergy and asthma drug Singulair and suicidal tendencies? The Food and Drug Administration (FDA) is looking into the possibility by "reviewing a handful of Read more...
Study: Clinical trials cut mortality rates at hospitals
Mortality rates at 494 hospitals around the country that participated in clinical trials for acute coronary syndrome declined, according to Modern Healthcare. Of 174,062 patients treated, only 3.5 Read more...
| Press ReleasesMMG Accelerates Global Patient Recruitment Innovation with Addition of Chris Middleton as VP of TechnologyROCKVILLE, Md., Feb. 8, 2012 /PRNewswire/ -- MMG, a global clinical trial patient recruitment group and part of Ketchum, today announced the addition of Chris Middleton as vice president of Read more >> PHT Corporation Achieves Record Bookings, Revenues and Profits in 2011 with Increased Global Adoption of its Innovative eCPHT captures 45% ePRO market share, celebrates 500 trials, expands PHT System to support late phase trials, breaks new ground in proving scientific and economic benefits of ePRO for collecting Read more >> BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology LaboratoryTest is Most Comprehensive Effort to Match Patient Tumor Profiles to Personalized Cancer Treatment Offered To Date ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- BioReference Laboratories, Inc. (NASDAQ: BRLI) Read more >> goBalto Completes a Successful FDA 21 CFR Part 11 Compliance AuditSAN FRANCISCO, Jan. 11, 2012 /PRNewswire/ -- goBalto, developer of new generation web-based clinical research solutions, announced that it successfully completed a FDA 21 CFR Part 11 compliance audit Read more >> DecisionView Enhances Market-Leading Clinical Enrollment Optimization Solution With Improved Cost ModelingDecisionView StudyOptimizer 4.4 Enables Clinical Trial Organizations To Easily Create and Compare Enrollment Scenarios With Different Timelines and CostsSAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- Read more >> |
